EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 262 filers reported holding EDITAS MEDICINE INC in Q3 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $233,142 | +0.9% | 29,890 | +6.5% | 0.00% | – |
| Q2 2023 | $231,049 | +18.1% | 28,074 | +4.0% | 0.00% | – |
| Q1 2023 | $195,721 | -18.3% | 26,996 | 0.0% | 0.00% | – |
| Q4 2022 | $239,455 | -27.8% | 26,996 | -0.3% | 0.00% | – |
| Q3 2022 | $331,545 | +0.9% | 27,087 | -2.4% | 0.00% | – |
| Q2 2022 | $328,484 | -37.9% | 27,767 | -0.2% | 0.00% | – |
| Q1 2022 | $529,308 | -42.3% | 27,829 | -19.6% | 0.00% | -100.0% |
| Q4 2021 | $918,000 | -35.8% | 34,593 | -0.7% | 0.00% | 0.0% |
| Q3 2021 | $1,431,000 | -33.9% | 34,837 | -8.9% | 0.00% | -50.0% |
| Q2 2021 | $2,165,000 | +38.3% | 38,224 | +2.5% | 0.00% | +100.0% |
| Q1 2021 | $1,566,000 | -40.3% | 37,294 | -0.4% | 0.00% | -50.0% |
| Q4 2020 | $2,625,000 | +163.3% | 37,443 | +5.4% | 0.00% | +100.0% |
| Q3 2020 | $997,000 | +2.8% | 35,520 | +7.4% | 0.00% | 0.0% |
| Q2 2020 | $970,000 | +48.5% | 33,073 | +0.4% | 0.00% | 0.0% |
| Q1 2020 | $653,000 | -26.6% | 32,949 | +9.6% | 0.00% | 0.0% |
| Q4 2019 | $890,000 | +27.5% | 30,060 | -3.2% | 0.00% | 0.0% |
| Q3 2019 | $698,000 | -9.2% | 31,065 | -0.1% | 0.00% | 0.0% |
| Q2 2019 | $769,000 | +3.1% | 31,096 | +2.0% | 0.00% | 0.0% |
| Q1 2019 | $746,000 | +12.3% | 30,491 | +4.6% | 0.00% | 0.0% |
| Q4 2018 | $664,000 | -30.8% | 29,164 | -3.3% | 0.00% | 0.0% |
| Q3 2018 | $960,000 | -21.3% | 30,163 | -11.4% | 0.00% | 0.0% |
| Q2 2018 | $1,220,000 | +31.6% | 34,058 | +21.7% | 0.00% | 0.0% |
| Q1 2018 | $927,000 | +12.2% | 27,981 | +4.1% | 0.00% | 0.0% |
| Q4 2017 | $826,000 | +29.9% | 26,879 | +1.5% | 0.00% | 0.0% |
| Q3 2017 | $636,000 | +41.3% | 26,489 | -1.3% | 0.00% | 0.0% |
| Q2 2017 | $450,000 | +210.3% | 26,837 | +311.5% | 0.00% | – |
| Q1 2017 | $145,000 | +245.2% | 6,521 | +153.0% | 0.00% | – |
| Q4 2016 | $42,000 | +27.3% | 2,577 | +4.8% | 0.00% | – |
| Q3 2016 | $33,000 | -72.5% | 2,458 | -49.9% | 0.00% | – |
| Q2 2016 | $120,000 | – | 4,904 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
| TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
| ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
| Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
| Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
| MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
| Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
| VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |